The criteria indicating the suitability of the endstage renal disease patients for renal replacement therapy(RRT) are still controversial. However, patient selection is a very important factor determining survival on RRT. In addition, 2-4% of the national budget for healthy care are spent for these therapies in developed countries. Therefore, the determination of the admittance criteria for these therapies are important.
If various reports about this issue are analysed, it may be suggested that serious uraemic symptoms and signs associated with impaired renal functions should be taken into account for patient selection to RRT.